News | January 14, 2025
Cube Biotech acquires IBA Lifesciences
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
If approved, sasanlimab would be the first PD-1 inhibitor, in combination with BCG, to significantly prolong event-free survival in this patient population
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The site’s GMP Certification has been successfully renewed
Acquisition expands high-value medical platform
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Subscribe To Our Newsletter & Stay Updated
